Objectives: Most outpatient parenteral antimicrobial therapy (OPAT) services use a hospital-based model of care in which patients remain in proximity to large hospitals facilitating clinical review. We aimed to evaluate clinical outcomes and complication rates for patients living in geographically isolated locations managed by telemedicine-supported OPAT.
Introduction
Outpatient parenteral antimicrobial therapy (OPAT) substitutes for inpatient care by enabling intravenous antimicrobial therapy to be administered within patients' homes. OPAT has been adopted worldwide and, when accompanied by appropriate patient selection and medical governance, it is safe, efficacious, cost-effective and improves patient productivity. [1] [2] [3] However, as most infectious diseases (ID) physicians practice within tertiary centres, ID-led OPAT services often use a hospital-based model of care, where patients remain in proximity of hospital clinics or infusion centres to facilitate clinical review.
Telemedicine refers to the use of telecommunication and information technologies to provide clinical healthcare to distant or isolated individuals. 4 Telemedicine has been successfully used in ID to manage chronic infections such as TB, HIV and viral hepatitis; however, its application to acute infections has been incompletely evaluated. 4 Although the IDSA Practice Guidelines for OPAT 1 endorses telemedicine and a recent European technical report recognized telemedicine 'plays a major role for the development of medicine and healthcare delivery in Europe', 5 surveys of OPAT practices in Europe, North America and Asia demonstrate limited uptake. 2, 6, 7 Western Australia (WA) encompasses 2645615 km 2 , which is approximately four times the size of France. One-third of Australians live outside of major cities, 8 posing unique challenges providing equity of care when OPAT is planned. In this study, we V C The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
report our novel experience combining OPAT with telemedicine to manage a large cohort of complex patients receiving OPAT for acute ID in a geographically vast location.
Methods
We retrospectively reviewed adult patients who received OPAT via telemedicine at Royal Perth Hospital between April 2011 and February 2015. Patients were identified from our existing OPAT database, with information then extracted from patient medical records.
Before acceptance on to the programme every patient had ID physician and OPAT nurse reviews to assess patient suitability. All telemedicinesupported OPAT procedures were in accordance with pre-existing, local written policies. Only antibiotics with stability data were used.
1 All antibiotics were administered via a peripherally inserted central catheter with first dose given prior to discharge. Antibiotics were given once daily by slow injection or continuous infusion using a 24 h elastomeric device. Antibiotic administration and other nursing requirements were performed by local nursing services; however, medical governance was retained by an ID physician. All patients had weekly laboratory monitoring performed and attended (accompanied by local nursing staff) a routine weekly videoconference for review by an ID consultant or fellow, utilizing government funded telemedicine facilities operating in hospitals throughout regional WA. Videoconferences were held at a bandwidth of 384 kilobits to 1 megabit per second via internet protocol. The hardware used was the Scopia desktop with a Logitech C170 webcam and Polycom HDX 7000 and 8000 systems.
Cure was defined as completion of OPAT with resolution of infection and no requirement for ongoing oral antibiotics. Improvement was defined as completion of the planned duration of OPAT followed by oral antibiotics. Failure occurred when there was: (i) progression or no improvement despite OPAT; (ii) unplanned re-admission related to OPAT; (iii) requirement for surgical intervention; or (iv) death. 9 Drug-related adverse events including rash, eosinophilia, hepatitis, myositis, cytopenias and acute kidney injury were as defined previously. 9 
Ethics
The Royal Perth Hospital Human Research Committee granted ethics approval for this study (HREC REG 15-022).
Results
During the study period, 88 OPAT telemedicine episodes of care were delivered to 83 patients. Sixty-one patients (74%) were male. Eight patients (10%) were indigenous Australian. The median patient age was 56 years (IQR 43-66). Diabetes was present in 31 patients (37%) and the median Charlson Comorbidity Index was 2 (IQR 1-4). Median travel distance (return) saved per telemedicine appointment was 576 km (IQR 402-1430). Thirty-seven (42%) episodes of care were provided in areas designated as remote or very remote according to the Australian Standard Geographical Classification.
10 Figure 1 illustrates the distribution of the episodes of care within WA.
The diagnoses and adverse events for all episodes of care managed via OPAT telemedicine are shown in Table 1 . Five infections involved MRSA, but there were no infections due to VRE or ESBL/carbapenemase-producing Enterobacteriaceae.
Piperacillin/tazobactam was the most commonly used antibiotic and was given in 27 of 88 episodes of care (31%), followed by flucloxacillin (27%), ertapenem (9%), cefazolin (8%), benzylpenicillin and vancomycin (7%), ceftriaxone and daptomycin (6%), and one episode of care (1%) each for aztreonam, cefepime, cefalotin, meropenem, tigecycline and gentamicin. Vancomycin steady-state levels were assessed weekly and 19 of 29 (66%) were within the target range.
The median duration of inpatient intravenous antibiotic administration prior to discharge on to the OPAT programme was 9 days (IQR 6-16). A total of 2261 OPAT days were supported via telemedicine, with a median duration of 26 days (IQR 14-34) per episode of care. Two hundred and thirty-eight telemedicine clinic appointments were performed with a median of 2 (range 0-17) per episode of care. On 8 (9%) occasions, the patients did not attend telemedicine appointments as planned.
Readmission was required during 17 episodes of care, of which 6 (7%) were planned, 4 (4%) were unplanned and unrelated to OPAT and 7 (8%) were unplanned and related to OPAT. In the latter group, four readmissions were due to infection progression requiring surgical intervention, two were due to antibiotic adverse events and one due to an occluded peripherally inserted central catheter. A favourable clinical outcome, as evident by either cure (11%) or improvement (76%), was achieved in 77 (87%) of episodes of care. No deaths occurred.
Discussion
To our knowledge, this is the most comprehensive study evaluating the outcomes of acute infections managed via a combination of OPAT and telemedicine. Compared with our own and other published non-telemedicine OPAT literature, 6,9,11,12 we achieved comparable rates of favourable clinical outcomes, low rates of line-and drug-related adverse events and low frequency of unplanned OPAT-related readmissions, suggesting our model of service delivery is safe and effective. Critical to our success was careful patient selection, which was ensured by review by an ID physician and OPAT nurse prior to acceptance on to the programme, in keeping with published recommendations. 13 The only published study of acute bacterial infections managed via OPAT and telemedicine involved a significantly smaller cohort of patients with relatively less complex infections compared with ours.
14 In this pilot study, performed over a decade ago, the clinical outcomes for the group managed via telemedicine (n " 25) were comparable with a historical inpatient control group; however, the inpatient length of stay and time to return to activities of daily living were significantly shorter for the group managed via telemedicine. The lack of direct comparison of outcomes versus a non-telemedicine OPAT group limits the generalizability of our findings and is an area that warrants further study to help address potential patient and clinician concerns about the utility of telemedicine in this clinical context. Forty-two percent of our patients were from remote and very remote areas based on the Australian Standard Geographical Classification. 10 Such geographic isolation creates unique challenges for healthcare delivery as these regions have less healthcare infrastructure and limited availability of healthcare professionals compared with the metropolitan populations. By combining telemedicine and OPAT we enabled more equitable access to ID specialist supervised OPAT services whilst minimizing costs and social disruption from travel. During the study period a total of 102748 km of travel was averted, avoiding direct expenses from both travel and accommodation as well as opportunity costs, for example by enabling patients to resume OPAT delivered via telemedicine JAC work earlier. Furthermore, direct access to specialist support promotes networks between physicians and primary care providers, which in turn enhances delivery of care and stability within regional healthcare systems. 15 In regions such as Europe where OPAT is experiencing growth, 3 partnering services with telemedicine could create opportunities for wider application and realization of these benefits. 16 This is a single-centre study, hence our findings should be applied to other settings with caution. We recognized that despite favourable clinical outcomes, patient satisfaction with our service was not formally assessed. However, most OPAT and telemedicine services are well received 1,4 and we had no formal patient complaints during the study period. Although we did not perform a formal analysis, by delivering 2261 days of OPAT care we believe our service, utilizing existing telemedicine infrastructure, to be cost effective, recognizing that health economic analyses of telemedicine are scarce. 17 Whilst some patients may prefer 'face-to-face' consultation, telemedicine services can facilitate this by ensuring the in-person assistance from a local nurse or medical practitioner during the telemedicine consultation.
In conclusion, our OPAT experience is a significant contribution to the accumulating evidence suggesting that geographically isolated patients with complex acute infections may be managed safely and effectively via telemedicine. This model of service delivery, if accompanied by careful patient selection, is likely to be cost effective, allows patients to convalesce in their home environment and should be considered for OPAT delivery for distant or isolated patients. Tan et al.
